Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00278174
What this trial is testing

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 7
Large-scale testing (Phase 3)Study completedNCT03849118
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 300
Testing effectiveness (Phase 2)Study completedNCT01196429
What this trial is testing

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaStage III Ovarian CancerStage IV Ovarian Cancer
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT01005329
What this trial is testing

Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+9 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)UnknownNCT00108745
What this trial is testing

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+24 more
GOG Foundation 1,157
Large-scale testing (Phase 3)Study completedNCT04227522
What this trial is testing

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
North Eastern German Society of Gynaecological Oncology 42
Testing effectiveness (Phase 2)Study completedNCT01307631
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01693822
What this trial is testing

A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Institute of Cancer Research, United Kingdom 65
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00557609
What this trial is testing

Phase 2 Study in Patients With MiT Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Alveolar Soft Part Sarcoma (ASPS)Clear Cell Sarcoma (CCS)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 47
Not applicableUnknownNCT06317298
What this trial is testing

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Who this might be right for
Renal Cell Carcinoma, Clear Cell, Somatic
Peking University First Hospital 36
Early research (Phase 1)Ended earlyNCT02386111
What this trial is testing

Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+6 more
Celldex Therapeutics 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07460206
What this trial is testing

Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment

Who this might be right for
ccRCC
Gruppo Oncologico Italiano di Ricerca Clinica 108
Testing effectiveness (Phase 2)Temporarily pausedNCT06860386
What this trial is testing

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 75
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05239533
What this trial is testing

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaKidney CancerAdvanced Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT05127824
What this trial is testing

Autologous Dendritic Cell Vaccine in Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Jodi Maranchie 42
Testing effectiveness (Phase 2)Study completedNCT02819596
What this trial is testing

MEDI4736 Combinations in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Clear Cell CarcinomaRenal Papillary Cell Carcinoma
Queen Mary University of London 69
Testing effectiveness (Phase 2)Study completedNCT02713386
What this trial is testing

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous Adenocarcinoma+23 more
NRG Oncology 147
Testing effectiveness (Phase 2)Active Not RecruitingNCT05043922
What this trial is testing

Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma

Who this might be right for
Ovarian CancerRecurrent Cancer
Haihe Biopharma Co., Ltd. 93
Next Page